Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 654.0 | 4,259.1 | 1,944.4 | 998.7 |
| Revenue growth | -84.6% | 119.1% | 94.7% | |
| Cost of goods sold | 109.4 | 554.6 | 240.2 | 137.8 |
| Gross profit | 544.6 | 3,704.5 | 1,704.1 | 860.9 |
| Gross margin | 83.3% | 87.0% | 87.6% | 86.2% |
| Sales and marketing | 290.1 | 1,942.7 | 1,347.5 | 916.8 |
| Research and development | 171.5 | 822.0 | 513.4 | 325.6 |
| General and administrative | 104.3 | 1,991.1 | 797.0 | 133.0 |
| EBIT | -18.8 | -1,036.3 | -944.9 | -511.9 |
| EBIT margin | -2.9% | -24.3% | -48.6% | -51.3% |
| Pre-tax income | 17.0 | -1,011.5 | -941.9 | -502.1 |
| Income taxes | 1.4 | 59.5 | 0.0 | 0.0 |
| Tax rate | 8.3% | | 0.0% | 0.0% |
| Net income | 15.5 | -1,235.1 | -1,225.9 | -734.4 |
| Net margin | 2.4% | -29.0% | -63.0% | -73.5% |
| |
| Diluted EPS | $0.00 | ($2.33) | ($11.03) | ($6.86) |
| Shares outstanding (diluted) | 872,301.3 | 529.3 | 111.2 | 107.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|